Holen Sie sich die Stockscreener-App
2.13
25.78%
-0.74
Handel nachbörslich:
2.12
-0.010
-0.47%
Schlusskurs vom Vortag:
$2.87
Offen:
$2.3
24-Stunden-Volumen:
2.65M
Relative Volume:
5.50
Marktkapitalisierung:
$147.39M
Einnahmen:
$3.64M
Nettoeinkommen (Verlust:
$-132.20M
KGV:
-0.7146
EPS:
-2.9806
Netto-Cashflow:
$-51.17M
1W Leistung:
-19.92%
1M Leistung:
-39.49%
6M Leistung:
+63.85%
1J Leistung:
+7.58%
1-Tages-Spanne:
$1.96
$2.30
1-Wochen-Bereich:
$1.96
$2.88
52-Wochen-Spanne:
$1.09
$4.1907
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.13 | 198.59M | 3.64M | -132.20M | -51.17M | -2.9806 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus (NASDAQ: CBUS) sells 6.98M Class A shares at $2.15 each - Stock Titan
Cibus stock dips after pricing $15M offering - MSN
Cibus announces underwritten public offering of Class A shares By Investing.com - Investing.com Australia
Cibus prices $15 million public offering at $2.15 per share By Investing.com - Investing.com India
Cibus sells nearly 7M shares to fund rice weed-trait development - Stock Titan
Cibus announces public offering of Class A common stock and pre-funded warrants - MSN
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 earnings call transcript - MSN
Cibus announces Class A common stock offering, no amount given - TipRanks
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Cibus (NASDAQ: CBUS) seeks capital via Class A shares and pre-funded warrants - Stock Titan
Cibus, Inc. Announces Proposed Public Offering Of Class A Common Stock And Pre-Funded Warrants - TradingView
Cibus seeks new capital for rice weed-trait work through stock sale - Stock Titan
Cibus (CBUS) Sees Analyst Laurence Alexander Raise Price Target - GuruFocus
Cibus (NASDAQ:CBUS) Price Target Raised to $3.00 at Jefferies Financial Group - MarketBeat
Cibus price target raised to $3 from $1.90 at Jefferies - TipRanks
Stock Report: Is Cibus Inc stock risky to hold nowPortfolio Risk Report & Pattern Based Trade Signal System - baoquankhu1.vn
Sidoti Brokers Increase Earnings Estimates for Cibus - MarketBeat
CBUS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cibus, Inc. (NASDAQ:CBUS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cibus Reports Q4 2025 Results, Advances Rice Program Toward 2027 Commercial Launch - iGrow News
Cibus, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cibus, Inc. Earnings Call Signals Promise Amid Pressure - TipRanks
Cibus Q4 Earnings Call Highlights - MarketBeat
Cibus (CBUS) Q4 2025 Earnings Call Transcript - AOL.com
Cibus Inc: Sr VP Sauer sells $5 in stock By Investing.com - Investing.com India
Cibus Inc: Sr VP Sauer sells $5 in stock - Investing.com
Cibus (CBUS) CFO logs small 1,496-share tax-withholding disposition - Stock Titan
Cibus (CBUS) SVP reports minor share sale and tax withholding - Stock Titan
Cibus (NASDAQ: CBUS) CLO reports 13,109-share tax-withholding dispositions - Stock Titan
Cibus Inc. Accelerates Crop Productivity with Proprietary Gene Editing Technologies and Rapid Trait Development System (RTDS) - Minichart
Cibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
Cibus targets $200M annual rice royalties with expanded Latin America and India push while advancing biofragrance commercialization - MSN
Cibus Inc (CBUS) Q4 2025 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus reports Q4 EPS (59c) vs. (87c) last year - TipRanks
Cibus, Inc. Q4 2025 Earnings Call Highlights - Intellectia AI
Cibus (CBUS) Sets Sights on Global Expansion with Promising Rice Program - GuruFocus
Cibus (CBUS) Reports Lower Q4 Revenue Amid Strategic Developments - GuruFocus
Cibus: 2025 Landmark Year in Gene Editing Commercialization & EU Regulatory ShiftNews and Statistics - IndexBox
Cibus (CBUS) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
Earnings call transcript: Cibus Q4 2025 shows cost cuts, stock up By Investing.com - Investing.com India
CIBUS ($CBUS) Releases Q4 2025 Earnings - Quiver Quantitative
Earnings call transcript: Cibus Q4 2025 shows cost cuts, stock up - Investing.com Australia
Cibus Inc’s 2025 Earnings Call: EU Gene Editing Timelines and Biofragrance Revenue Roadmaps Clash - Bitget
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Cibus 2025 Financial Results: Quarterly and Annual Revenue & LossNews and Statistics - IndexBox
Cibus (NASDAQ:CBUS) Releases Earnings Results, Misses Expectations By $0.16 EPS - MarketBeat
Cibus: Q4 Earnings Snapshot - marketscreener.com
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus 2025 10-K: Revenue $3.6M, EPS loss $2.78 - TradingView
Cibus (NASDAQ: CBUS) doubles down on gene-edited rice traits amid funding risk - Stock Titan
Cibus Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):